CA 15-3 Tumer Marker by zozoomda

VIEWS: 27 PAGES: 2

More Info
									CA 15-3
Also known as: CA-Breast; Cancer antigen-breast
Formal name: Cancer Antigen 15-3
Related tests: CA 27.29; Tumor markers; CEA; Her2/neu; Hormone Receptor
Status; Gene Expression Tests for Breast Cancer

The Test

    How do you use?
    When is it ordered?
    What is the result?
    Is there anything else I should know?

How do you use?

CA 15-3 is not sensitive or specific enough to be considered useful as a
tool for cancer detection. Its main use is to control a person's response
to the treatment of breast cancer and to monitor the recurrence of breast
cancer. CA 15-3 is sometimes ordered to give a doctor a general idea of
??the amount of cancer may be present (tumor burden). CA 15-3 can only be
used as a marker if the cancer is producing large quantities of it, so
this test is not useful for all breast cancer patients.


When is it ordered?

CA 15-3 may be ordered along with other tests, such as estrogen and
progesterone receptors, HER2/neu, and gene expression tests for breast
cancer, when advanced breast cancer was first diagnosed to help determine
the characteristics of cancer and treatment options. If the CA 15-3
initially rises, then you can order to monitor treatment efficacy and to
detect recurrence. CA 15-3 is usually ordered when breast cancer is
detected early, before it has metastasized, as the levels are not
elevated in the majority of early cancers.

What is the result?

In general, the higher the level of CA 15-3, the more advanced breast
cancer and the larger tumor burden. CA 15-3 concentrations tend to
increase as the cancer grows. In metastatic breast cancer, higher levels
of CA 15-3 are often observed when the cancer has spread to the bones and
/ or liver.

Mild to moderate elevations of CA 15-3 was seen in a variety of
conditions, including liver and pancreas cancer, cirrhosis and benign
breast diseases, as well as a certain percentage of apparently healthy
individuals. CA 15-3 elevations observed in non-cancerous conditions tend
to be stable over time.

Normal levels of CA 15-3 does not guarantee that a person is not
localized breast cancer or metastatic. Perhaps it is too early in the
disease for elevated levels of CA 15-3 to be detected or the person may
be one of the 25% to 30% of people with advanced breast cancer whose
tumors do not shed CA 15-3.
The increased concentrations of CA 15-3 over time can indicate that a
patient is not responding to treatment or recurrent cancer.


Is there anything else I should know?

The levels of CA 15-3 is often not measured immediately after treatment
for breast cancer begins. There have been cases of transient increases
and decreases in CA 15-3 is not related to the progress of the
individual. Usually the doctor will wait a few weeks after starting
treatment to begin monitoring CA 15-3 levels.

CA 15-3 may be elevated in other malignant tumors of breast, lung,
pancreas, ovary, liver and colorectal cancer.

								
To top